Company intelligence / Profile preview

ResearchDx

Irvine, California, United Statesresearchdx.com ↗

Ownership: Private
Development stage: Commercial

Overview

ResearchDx has successfully supported the FDA clearance of companion diagnostics such as the GlutenID Celiac Genetic Health Risk Test. Their PacificDx clinical laboratory holds CLIA/CAP accreditations. They have enabled clients to achieve regulatory milestones including FDA clearances and CAP certifications for novel diagnostic tests in areas like celiac disease risk assessment and prostate cancer.

Therapeutic areas: GastroenterologyOncologyWomen's Health
Modalities: Molecular diagnostics (PCR, qPCR, ddPCR)NGS (Next Generation Sequencing)microRNA assaysProtein assays/ELISAFlow cytometryCustom and OEM assay development/manufacturing
Industry: Molecular Diagnostics

Partnerships

Targeted GenomicsProstatype GenomicsHeranova Biosciences

Beyond the preview

Go deeper on ResearchDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ResearchDx.

Explore the full profile